News Apr 19, 2016 CardioCell Completes Enrollment For A Phase IIa Clinical Trial Using Its Stem Cells For Participants With Chronic Heart Failure CardioCell LLC, a global biotechnology company that uses allogeneic stem cells for cardiovascular indications, fulfills enrollment for its
Read MoreCardioCell Completes Enrollment for a Phase IIa Clinical Trial Using Its Stem Cells for Participants With Chronic Heart Failure
News Apr 19, 2016 CardioCell Completes Enrollment for a Phase IIa Clinical Trial Using Its Stem Cells for Participants With Chronic Heart Failure SAN DIEGO — April 19, 2016 — CardioCell LLC, a global biotechnology company that uses allogeneic stem cells for cardiovascular
Read MoreCardioCell Expands Chronic Heart Failure Phase Ila Clinical Trial To MedStar Washington Hospital Center
News Mar 22, 2016 CardioCell Expands Chronic Heart Failure Phase Ila Clinical Trial To MedStar Washington Hospital Center CardioCell LLC, a Stemedica Cell Technologies Inc. subsidiary that uses allogeneic stem cells for cardiovascular indications, welcomes MedStar Washington Hospital
Read MoreCardioCell Expands Chronic Heart Failure Phase IIa Clinical Trial to MedStar Washington Hospital Center
News Mar 22, 2016 CardioCell Expands Chronic Heart Failure Phase IIa Clinical Trial to MedStar Washington Hospital Center WASHINGTON, D.C — March 22, 2016 — CardioCell LLC, a Stemedica Cell Technologies Inc. subsidiary that uses allogeneic stem cells for cardiovascular indications,
Read More
European Society of Cardiology Congress 2016
Events European Society of Cardiology Congress 2016 Aug. 27-31 Rome, Italy
Read More
European Society of Cardiology Heart Failure 2016
Events European Society of Cardiology Heart Failure 2016 May 21-24, 2016Florence, Italy
Read MoreClinical Trial Will Study Novel Stem Cells in Cardiac Patients
News Jan 6, 2016 Clinical Trial Will Study Novel Stem Cells in Cardiac Patients When stem cell research targeted to cardiovascular disease first made headlines almost two decades ago, many speculated it would create a new era of medical therapy for acute myocardial infarction and
Read MoreCardioCell Appoints Timothy Brown, J.D., as Vice President of Intellectual Property
News Dec 16, 2015 CardioCell Appoints Timothy Brown, J.D., as Vice President of Intellectual Property SAN DIEGO — Dec. 16, 2015 — CardioCell LLC, a Stemedica Cell Technologies Inc. subsidiary that uses allogeneic stem cells for cardiovascular indications, today welcomes Timothy M.
Read More